Nasus Pharma Ltd. (NSRX)

Exscientia Statistics

Total Valuation

Nasus Pharma has a market cap or net worth of $81.09 million. The enterprise value is $82.58 million.

Market Cap	81.09M
Enterprise Value	82.58M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Nasus Pharma has 9.01 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-51.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-213.67%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.08M
Pretax Income	-1.53M
Net Income	-1.53M
EBITDA	-1.50M
EBIT	-1.50M
Earnings Per Share (EPS)	-$0.17

Balance Sheet

The company has $311,000 in cash and $1.80 million in debt, giving a net cash position of -$1.49 million or -$0.17 per share.

Cash & Cash Equivalents	311,000
Total Debt	1.80M
Net Cash	-1.49M
Net Cash Per Share	-$0.17
Equity (Book Value)	-3.21M
Book Value Per Share	-0.36
Working Capital	-3.47M

Cash Flow

Operating Cash Flow	-665,000
Capital Expenditures	n/a
Free Cash Flow	-665,000
FCF Per Share	-$0.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nasus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.89%
FCF Yield	-0.82%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a